Edgar Filing: STELAX INDUSTRIES LTD

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K

(Mark One)
(X) Annual report pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 for the fiscal year ended
March 31, 2002 or

( ) Transition report pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 for the transition period from
______ to ________.

STELAX INDUSTRIES LTD.
(Exact name of registrant as specified in its charter)
Commission file number 0-18052

British Columbia, Canada None
------------------------------------------------------------------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)

4287-A Beltline Road, # 105, Addison, Texas 75001
------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: (972) 233-6041

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, no par value
(Title of Class)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding twelve (12) months and (2) has been subject to such filing
requirements for the past ninety (90) days.
Yes X No
----- -----

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405
of Regulation S-K is not contained herein, and will not be contained, to the
best of the registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. [ ]

The aggregate market value of the voting stock held by non-affiliates of the
Registrant as of July 12, 2001 was approximately $21,413,122. At March 31, 2002
there were 43,184,775 shares of common stock outstanding.

Documents Incorporated by Reference
NOT APPLICABLE

PART I

ITEM 1. BUSINESS

Introduction

Stelax Industries Ltd. (the "Registrant") was incorporated under the laws of
British Columbia, Canada in May 1987. The Registrant's principal activities are
conducted through its wholly-owned subsidiary, Stelax (U.K.) Limited, a
corporation organized under the laws of the United Kingdom ("Stelax (U.K.)").
The Company owns certain real and personal property in Wales, United Kingdom
comprising the Aberneath steel mill facilities (the "Aberneath Facility").
Stelax (U.K.) produces two separate product lines through the Aberneath
Facility: (i) Nuovinox(TM), a stainless steel cladded product with a carbon
steel core utilizing the Company's unique patented manufacturing process and
(ii) steel abrasive shot pellets which are used as an abrasive cleaner and
polisher in steel manufacturing. See "--- Products", below.

Originally incorporated as Zfax Image Corp, until 1992 the Registrant was
engaged in the development and production of a portable facsimile machine using
certain advanced facsimile technology. On March 31, 1995, the Registrant sold
this business to the Company's president for book value.

On November 15, 1995, the Company finalized agreements to acquire the real,
personal and intellectual property comprising the Aberneath steel mill facility,
paying cash of approximately $1,377,000 and issuing 2,925,000 shares of Common
Stock and assuming debt of approximately $1,316,000. The registrant acquired the
facility from an entity that had gone into receivership in 1992. The then owner
had maintained but not operated the facility after entering into receivership
but prior to being acquired by the Registrant. The Registrant financed the
acquisition principally through the issuance of $600,000 in convertible notes,
which were subsequently converted, and the sale of $1,540,000 of Common Stock
and Warrants.

In July 1996, the Registrant sold 10,800,000 shares of Common Stock, raising
$10,831,000. Approximately $1,100,000 of the proceeds were used to liquidate
outstanding mortgages on the Aberneath property. As part of this financing, the
Registrant's Common Stock began trading on the Le Nouveau Marche of the Paris
Stock Exchange.

Beginning in fiscal 1997, the Registrant commenced operations from Aberneath
plant, principally producing stainless steel. The Registrant also began
developing the market for the Nuovinox product. In 1998, the market for
stainless steel was subject to severe pricing pressures, and the Company
determined to cease production of stainless steel while the Registrant developed
the Nuovinox market. Operating losses since 1997 essentially depleted the
Registrant's working capital.

In the first quarter of fiscal 2001, the Registrant began receiving orders for
the Nuovinox product, In July 2000, with its assets unencumbered, the Registrant
obtained financing from Bank of America so that the Registrant could fulfill
those orders. This financing provided $5,000,000 of a term loan, $500,000 of
receivable financing and $250,000 inventory financing. Bank of America
subsequently assigned this obligation to Wells Fargo. While the Registrant made
some shipments in fiscal 2001, the registrant expended resources on new mill
tooling, completing a finishing line and improving Nuovinox metallurgical
properties and product quality.

The Registrant's U.K. subsidiary commenced quantity production in the quarter
ended June 2001 but was unable to increase production for sufficiently large
volumes to obtain profitability or service debt. In March 2002 the Registrant's
U.K. subsidiary was placed into receivership and the receiver acquired the
assets of the U.K. subsidiary, and the assets were subsequently transferred to
Wells Fargo Business Credit, Inc. The Registrant's operations thus ceased.

The Registrant has entered into a letter of intent with Wells Fargo Business
Credit, Inc. to acquire for $1,750,000 all of the assets formerly owned by the
U.K. subsidiary off Wells Fargo Business Credit Inc. The letter of intent also
contemplates granting to Wells Fargo Business Credit Inc. a warrant to purchase
500,000 shares of the Registrant's Common Stock. The Registrant anticipates
entering in the near future into a formal agreement to fund the reacquisition of
these assets and obtain operating capital and commence production soon
thereafter.

The Registrant's principal executive offices are located at 4004 Beltline Rd.,
Suite 107, Dallas, Texas 75244, and its telephone number is (972) 233-6041.
Unless otherwise required by the context, the term "Company" as used herein
shall mean the Registrant and Stelax (U.K.). The Registrant changed its name
from ZFAX Image Corp. to its present name in May 1996.

The Aberneath Facility

The Aberneath Facility is located at Briton Ferry, Neath in South Wales, United
Kingdom. The facility is located on the banks of the River Neath beside a deep
water wharf and close to highway and national rail links. The facility includes
approximately five acres of land. The steel mill plant is divided into three
bays, each approximately 650 feet long, for a total of approximately 130,000

square feet of production space. There is a separate building on the premises
with approximately 8,000 square feet of office and administrative space.

The facility has an open air storage and preparation area covering approximately
two acres of land for the purpose of preparing scrap metal for use in the
Company's Nuovinox product. The interior of the plant contains a modern walking
beam furnace, a rolling mill, a cooling and finishing area and a quality control
process area. All production areas in the plant are serviced by overhead
gantries or pedestal mounted or mobile cranes.

During the year ended March 31, 2000, the Company produced limited quantities of
Nuovinox for use by potential customers in their testing and evaluation of the
product. During the fiscal year ended March 31, 2001, the Company sold limited
quantities of its Nuovinox product. Some production occurred in the fiscal year
ended on March 31, 2002 but the Company had depleted its capital resources which
ultimately resulted in a receiver acquiring the Aberneath facility which was
subsequently sold to Wells Fargo Business Credit, Inc.

Products

The Aberneath facility is capable of producing two distinct product lines: (i)
the Company's patented Nuovinox product, a stainless steel cladded product with
metallurigically joined carbon steel core and (ii) steel abrasive shot in
various sizes marketed under the name Stelablast.

Nuovinox is a carbon steel product cladded with stainless steel. From raw
stainless steel the Registrant creates tubes several inches in diameter and
fills the tubes with treated scrap steel, reducing and elongating the tubes in a
proprietary process until the desired product is created, usually rebar 1/2 inch
or larger in diameter with a core of carbon sheet and an outer casing of
stainless steel. While the Registrant believes that the most commonly produced
product will be rebar, Nuovinox can be manufactured in flat bar, round bar and
pipes of various sizes and dimensions. The resultant product, which generally
consists of up to 25% of stainless steel by weight, has created a molecular bond
between the carbon steel core and the stainless steel exterior. The raw
materials for the rebar comes from very low grade scrap steel, which the
Registrant believes to be in adequate supply at its facility in the U.K.

Nuovinox has corrosion resistant properties comparable to stainless steel and
achieves superior level of mechanical strength when compared with solid
stainless steels manufactured by other parties. The Company prices its Nuovinox
at approximately one-third of the price of stainless steel products.

The properties of the stainless steel cladding enable Nuovinox to be used for
many applications which require an upgrading of carbon steel or a substitute for
stainless steel, in particular where corrosion resistance, hygiene and
aesthetics are determining factors. Although it has not been extensively
marketed, the Company believes there is considerable interest in Nuovinox from
customers around the world who have expressed their intention of using the
product in a variety of applications.

The Company believes Nuovinox will compete with carbon and stainless steel based
on the following properties and characteristics of Nuovinox:

" High level of corrosion resistance;

" Stronger than pure stainless steel (when incorporating a high
tensile carbon steel core);

" Strength and ductility superior to mild steel; and

" Minimal maintenance when incorporated in structures.

The abrasive products produced by the Company are produced as a by-product of
the process used in producing Nuovinox. The Registrant believes that its
abrasive product, Stelablast, offers a superior and longer lasting shot blast
than conventional cast steel shot at a price of approximately 44% of
conventional cast steel shot.

Customers and Distribution

During the 2000, 2001 and 2002 fiscal years, the Company distributed its
Nuovinox and abrasive products through its direct marketing efforts. Over the
last several years, the Registrant has developed contacts with United States and
Federal and State transportation authorizations, confirming the utility of
Nuovinox for highways and bridges.

In 1997, the United States passed the Intermodel Surface Transportation Act to
test for new materials used in highway construction with a goal of achieving a
75 to 100 year life objective for bridges and highways. Existing highway life is
approximately 25 years, largely because rebar and dowels rust, expand, and break
down roads and bridges, particularly in high corrosive areas near salt water.
Dowels are used to pin concrete highway sections that are about 15 feet apart
with each lane requiring 12 dowels per join. While stainless steel can be used
for pins and rebar in concrete highways, particularly in high corrosive areas,
stainless steel costs approximately three times that of Nuovinox.

Industry Conditions and Competition

The steel industry is generally considered to be highly competitive and cyclical
with a great number of large and sophisticated producers, all of whom have
greater financial and technical resources than the Company. Additionally, the
cycles for steel products vary from one specialty steel to another.

Economic conditions among end-users of steel products may result in cyclical
downturns in business, even in markets expected to expand over the long term.
Until a wide range of different products used in varying sections is produced by
the Company, such downturns may have a significant impact on the Company's
revenues.

Nuovinox is a new product that has been extensively tested. During the 2001
fiscal year, the Company has received various commitments for the use of the
product. Further product acceptance may be affected by pricing and the other
variables beyond the Company's control. Management of the Company is not aware
of any product other than pure stainless steel that competes directly with
Nuovinox.

Currency Fluctuations

It is anticipated that the Company's expenses and sales will be denominated in
several currencies, including major European currencies, the US Dollar and the
Yen. As a result the Company's operating income and cash flow will be
significantly exposed to currency fluctuations. Management intends to monitor
the Company's exposure to currency risks, and, as appropriate, use financial
forward or other instruments to minimize the effect of these fluctuations. No
such instruments were held as of March 31, 2001 and there can be no assurance
that the Company would be able to obtain such instruments. However, there can be
no assurance that exchange rate fluctuations will not have an adverse effect on
the Company's results of operations or financial condition.

Research and Development

During the last three fiscal years the Company has not spent any amounts on
research and development. In the future, amounts may be incurred as specific
customer requirements may arise in connection with the sale of customized
Nuovinox products.

Patents and Trademarks

The Company holds approximately 70 worldwide patents for Nuovinox. The Company
considers its patents important for the success of such product.

Employees

As of August 15, 2002, the Company had 4 employees or independent contractors
working for the Company. The Company anticipates increasing the number of
employees in the 2003 fiscal year as the Company expands production at the
Aberneath Facility.

ITEM 2. PROPERTIES

The Company's principal executive offices in the United States are located
4287-A Beltline Road, # 105, Addison, Texas 75001 and are occupied pursuant to a
month to month lease. Until acquired by a receiver in March 2002 the Company
owned the land and buildings comprising the Aberneath Facility in Wales, United
Kingdom. See Item 1. Business - The Aberneath Facility. The Company has a letter
of intent with the purchaser from the receiver, Wells Fargo Business Credit,
Inc., to reacquire the facility for $1,750,000 and a qarrant to purchase 500,000
shares of the Company's Common Stock.

ITEM 3. LEGAL PROCEEDINGS

The Company is not a party to any material pending legal proceedings. The
proceedings in the UK by the receiver whereby the receiver acquired the
Aberneath facility have been completed.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

Not applicable.

PART II

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

Market Information

The Registrant's Common Stock is quoted on the NASDAQ Bulletin Board System. The
Registrant's Common Stock in the United States trades under the symbol "STAX".
They represent inter-dealer prices and do not represent actual transactions. The
range of the closing high and low bid and prices as quoted on the NASDAQ
Bulletin Board from April 1, 1999 through March 31, 2001 is as follows:

Bid Ask
Fiscal 2001 High Low High Low
----------- ---- --- ---- ---

First Quarter 1.6875 0.875 1.8125 0.98
Second Quarter 1.25 0.35 1.375 0.38
Third Quarter 0.65 0.30 0.70 0.35
Fourth Quarter 0.505 0.28 0.54 0.35

Fiscal 2002 High Low High Low
----------- ---- --- ---- ---

First Quarter 0.81 0.32 0.87 0.36
Second Quarter 0.70 0.25 0.73 0.27
Third Quarter 0.91 0.23 0.97 0.26
Fourth Quarter 0.75 0.24 0.78 0.27

The Registrant's Common Stock is also quoted on the Le Nouveau Marche of the
Paris Stock Exchange. Trading on the Le Nouveau Marche commenced July 11, 1996.

Holders

As of August 15, 2002, there were approximately 200 holders of record of the
Registrant's Common Stock.

Dividends

The future payment by the Registrant of dividends, if any, rests within the
discretion of its Board of Directors and will depend upon the Registrant's
earnings, if any, capital requirements and the Registrant's financial condition,
as well as other relevant factors. The Registrant has not declared dividends
since its inception, and has no present intention of paying cash dividends on
its Common Stock in the foreseeable future, as it intends to use earnings, if
any, to generate growth.

Foreign Regulation

The Investment Canada Act ("ICA"), which became effective on June 30, 1985,
regulates the acquisition by non-Canadians of control of a Canadian business
enterprise. In effect, the ICA required review by Investment Canada, the agency
which administers the ICA, and approval by the Canadian government in the case
of an acquisition of control of a Canadian business by a non-Canadian where: (i)
in the case of a direct acquisition (for example, through a share purchase or
asset purchase), the assets of the business are $5 million or more in value; or
(ii) in the case of an indirect acquisition (for example, the acquisition of the
foreign parent of the Canadian business) where the Canadian business has assets
of $50 million or more in value or if the Canadian business represents more than
50% of the assets of the original group and the Canadian business has assets of
$5 million or more in value. Review and approval are also required for the
acquisition or establishment of a new business in areas concerning Canada's
cultural heritage or national identity such as book publishing, film production
and distribution, television and radio, production and distribution of music,
and the oil and natural gas industry, regardless of the size of the investment.

In the context of the Company, in essence, three methods of acquiring control of
a Canadian business are regulated by the ICA: (i) the acquisition of all or
substantially all of the assets used in carrying on the Canadian business; (ii)

the acquisition, directly and indirectly, of voting shares of a Canadian
corporation carrying on the Canadian business; (iii) the acquisition of voting
control of an entity which controls, directly or indirectly, another entity
carrying on a Canadian business. An acquisition of a majority of the voting
interests of an entity, including a corporation, is deemed to be an acquisition
of control under the ICA. An acquisition of less than one-third of the voting
shares of a corporation is deemed not to be an acquisition of control. An
acquisition of less than a majority, but one-third or more, of the voting shares
of a corporation is presumed to be an acquisition of control unless it can be
established that on the acquisition the corporation is not, in fact, controlled
by the acquirer through the ownership of voting shares. For partnerships,
trusts, joint ventures or other unincorporated entities, an acquisition of less
than a majority of the voting interests is deemed not to be an acquisition of
control.

In 1988, the ICA was amended pursuant to the Free Trade Agreement dated January
2, 1988 between Canada and the United States to relax the restrictions of the
ICA. As a result of these amendments, except where the Canadian business is in
the cultural, oil and gas, uranium, financial services or transportation
sectors, the threshold for direct acquisition of control by U.S. investors and
other foreign investors acquiring control of a Canadian business from U.S.
investors has been raised from $5 million to $150 million of gross assets, and
indirect acquisitions are not reviewable.

In addition to the foregoing, the ICA requires that all other acquisitions of
control of Canadian businesses by non-Canadians are subject to formal
notification to the Canadian government. These provisions require a foreign
investor to give notice in the required form, which notices are for information,
as opposed to review, purposes.

The Company does not believe that it is subject to the provisions of ICA because
it does not have a place of business or employees in Canada nor assets in Canada
used to carry on the Company's business, all of which are definitional
requirements to be considered a Canadian business subject to such act. The
Company does not plan to alter its contacts with Canada and, therefore, believes
that ICA will continue not to be applicable to the Common Stock of the Company
and the acquisition thereof by a non-resident or non-citizen of Canada. However,
in the event that management of the Company should for whatever reason decide
that it would be in the best interests of the Company to hire employees in
Canada, lease office space in Canada or acquire properties in Canada, the
Company would probably be deemed to be a Canadian based enterprise and ICA would
be applicable.

Certain Tax Matters

Following is a brief summary of the United States and Canadian federal income
tax provisions which the Company believes are material to an understanding of
the federal income tax matters relating to the ownership of the Company's Common
Stock. The discussion is for general information only and is not a complete
description of all potential consequences which may arise or of all the rules
that may be relevant to certain stockholders. The discussion is not intended to
be, nor should it be construed to be, legal or tax advice to any particular
stockholder. It is the responsibility of each stockholder of the Company to
consult with his own tax advisors with respect to these and other provisions
which may affect his individual tax position.

The presently existing tax treaty between the United States and Canada
essentially calls for taxation of stockholders by the stockholder's country of
residence. In those instances in which a tax may be assessed by the other
country, a corresponding credit against the tax owed in the country of residence
is normally available. Stockholders of the Registrant should consult with their
own tax advisors, however, for full details.

A. United States Taxes.

In general, a stockholder that is a non resident alien will not be
taxed by the United States on dividends paid by the Registrant.
However, a non resident alien stockholder who engages in a U.S.
business under certain circumstances may be subject to United States
federal income tax. Also, a non resident alien may be subject to United
States withholding tax on dividends paid by the Registrant, though a
tax treaty may alter this treatment. Please consult your tax advisor
regarding the impact of applicable tax treaties.

The gross amount of dividends received by a United States individual or
United States resident will be subject to United States federal income
tax generally in the same manner as dividends received from United
States corporations. However, the stockholder generally may claim a
credit against his United States federal income tax liability for the
Canadian tax withheld from the dividend payment. The amount of the
foreign tax credit is subject to various limitations. Stockholders
should consult their own tax advisors with respect to such limitations.
Dividends from foreign corporations such as the Registrant do not
qualify for the dividends received deduction for corporate stockholders
under Code Section 243, but may qualify for the dividends received

deduction for dividends paid by certain foreign corporations under Code
Section 245 if the holder owns at least 10% of the stock of the
Registrant by vote and value.

Except in the case of shares beneficially owned by a person who is or
is deemed to be a resident of the United States or has or is deemed to
have a "permanent establishment" in the United States, United States
federal income tax consequences generally will not arise upon a
disposition of the Registrant's Common Stock by a resident of Canada.
The United States federal income tax consequences arising for a United
States resident upon a disposition of the Registrant's Common Stock
will depend upon whether such shares are capital assets. Generally, if
the disposed stock is a capital asset, the entire gain or loss realized
upon the disposition would be treated as capital gain or loss. Such
capital gain or loss will be long-term if the Common Stock is held for
more than one year. However, even if the shares are considered capital
assets, under certain circumstances a portion of the gain may be
recharacterized as ordinary income under Code Section 1248. If the
disposed stock is not a capital asset, the entire gain or loss would be
treated as ordinary income or loss.

Capital gains income generally is taxed at a maximum tax rate of 28%.
An individual's capital losses are still allowed in full against
capital gains. In addition, capital losses are allowed against up to
$3,000 of ordinary income, and the excess of net long-term capital loss
over net short-term capital gain is allowed in full for this purpose.

B. Canadian Taxes.

The following is a summary of the principal Canadian federal income tax
considerations generally applicable in respect of the Common Shares.
The tax consequences to any particular holder of Common Shares will
vary according to the status of that holder as an individual, trust,
corporation, or member of a partnership, the jurisdiction in which that
holder is subject to taxation, the place where that holder is resident
and, generally, according to that holder's particular circumstances.
This summary is applicable only to holders who are resident in the
United States, have never been resident in Canada, hold their Common
Shares as capital property, and will not use or hold the Common Shares
in carrying on business in Canada.

This summary is based upon current provisions of the Income Tax Act of
Canada and the regulations thereunder (collectively, the "ITA"),
publicly-announced current proposals to amend the ITA and the current
administrative practices of Revenue Canada. This summary does not take
into account provincial income tax consequences. The summary assumes
that the publicly announced current proposals will be enacted as
proposed with effective dates set out therein; otherwise, the summary
assumes that there will be no other changes in law whether by judicial
or legislative action.

This summary is of a general nature only and is not exhaustive of all
possible income tax consequences. It is not intended as legal or tax
advice to any particular holder of Common Shares and should not be so
construed. Each holder should consult his own tax advisor with respect
to the income tax consequences applicable to him in his own particular
circumstances.

Disposition of Common Shares

Under the ITA, a gain from the sale of Common Shares by a non-resident will not
be subject to Canadian tax, provided the shareholder (and/or persons who do not
deal at arm's length with the shareholder) has not held a "substantial interest"
in the Registrant (25% or more of the shares of any class of the Registrant's
stock) at any time in the five years preceding the disposition. Generally, the
Canadian-United States Tax Convention (the "Tax Convention") will exempt from
Canadian taxation any capital gain realized by a resident of the United States,
provided that the value of the common stock is not derived principally from real
property situated in Canada.

If a non-resident was to dispose of Common Shares to another Canadian
corporation which deals or is deemed to deal on a non-arm's length basis with
the non-resident and which, immediately after the disposition, is connected with
the Registrant (i.e., controls the Registrant or holds shares representing more
than 10% of the voting power and more than 10% of the market value of all issued
and outstanding Common Shares of the Registrant), the excess of the proceeds
over the paid-up capital of the Common Shares sold will be deemed to be taxable
as a dividend either immediately or eventually by means of a deduction in
computing the paid-up capital of the purchasing corporation.

Dividends

In the case of any dividends paid to non-residents, the Canadian tax is withheld
by the Registrant, which remits only the net amount to the shareholder. By
virtue of Article X of the Tax Convention, the rate of tax on dividends paid to
beneficial owners who are residents of the United States is generally limited to
15% of the gross dividend (or 10%, reducing to 6% in 1996 and 5% in 1997 and
thereafter, in the case of certain corporate shareholders owning at least 10% of
the Registrant's voting shares). In the absence of the treaty provisions, the
rate of Canadian withholding tax imposed on non-residents is 25% of the gross
dividend. Stock dividends received by non-residents from the Registrant are
treated by Canada as ordinary dividends.

ITEM 6. SELECTED FINANCIAL DATA

The table below sets forth certain financial data for the Company for its fiscal
years ended March 31, 2002 to 1998. and should be read in conjunction with the
Consolidated Financial Statements and Notes thereto included elsewhere herein.

YEARS ENDED MARCH 31,
2002 2001 2000 1999 1998

Sales $ 559,170 $ 304,377 $ 136,191 $ 251,025 $ 1,728,657
Gross Loss (894,229) (716,832) (657,930) (1,121,224) (2,725,973)
Net Loss (10,567,768) (2,902,573) (2,279,926) (3,150,498) (4,691,161)
Total Assets 251,516 10,470,398 9,727,826 10,065,688 12,636,869
Long Term Obligations - 2,916,666 - - -
Total Liabilities 5,322,214 5,932,635 2,811,683 1,663,437 2,110,615
Common Stock Outstanding at year end 43,184,775 39,240,175 37,521,442 35,963,729 31,869,285
Net Loss per share $ (0.25) $ (0.10) $ (0.06) $ (0.10) $ (0.15)

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

Forward-Looking Statements - Cautionary Statements. This Annual Report contains
certain "forward-looking statements" within the meaning of Section 27A of the
Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of
the Securities Exchange Act of 1934, as amended (the "Exchange Act").
Specifically, all statements other than statements of historical facts included
in this report regarding the Company's financial position, business strategy and
plans and objectives of management of the Company for future operations are
forward-looking statements. These forward-looking statements are based on the
beliefs of the Company's management, as well as assumptions made by and
information currently available to the Company's management. When used in this
report, the words "anticipate," "believe," "estimate," "expect," and "intend"
and words or phrases of similar import, as they relate to the Company or Company
management, are intended to identify forward-looking statements. Such statements
reflect the current view of the Company with respect to future events and are
subject to risks, uncertainties and assumptions related to various factors
including, without limitation, competitive factors, general economic conditions,
customer relations, increases in raw material prices, governmental regulation
and supervision, seasonality, acceptance of the Company's Nuovinox products in
the marketplace, technological changes and changes in industry practices
("cautionary statements"). Although the Company believes that its expectations
are reasonable, it can give no assurance that such expectations will prove to be
correct. Based upon changing conditions, should any one or more of these risks
or uncertainties materialize, or should any underlying assumptions prove
incorrect, actual results may vary materially from those described herein as
anticipated, believed, estimated, expected or intended. All subsequent written
and oral forward-looking statements attributable to the Company or persons
acting on its behalf are expressly qualified in their entirety by the applicable
cautionary statements.

Liquidity and Capital Resources

In fiscal 1999 and 2000 the Company ceased production and sales of stainless
steel and developed the market for its Nuovinox product, much of which involved
extensive testing for United States federal and state transportation authorities
to demonstrate the utility of the Nuovinox product in bridges and highways. By
the end of fiscal 2000, this process was sufficiently successful and complete to
begin sales. With the Company's plant facilities unencumbered, in July 2000 the
Company's United States subsidiary entered into a Loan and Security Agreement
with Bank of America Commercial Finance Corporation (the "Loan Agreement")
whereby the Company obtained a Term Loan as well as Revolving Credit and Credit
Accommodations. The maximum amount that can be borrowed under the Loan Agreement
is $5,750,000.

The proceeds from the term loan were used to fund operational losses to the
extent necessary to cover the start up period for Nuovinox sales and to finance
inventory and receivables to the extent that the Company will need funds in
excess of borrowing under the Term Loan for inventory and receivables.

Financially, the Company had to achieve positive cash flow, including debt
service, from the capital provided from the Loan Agreement. This goal seemed
achievable because the Nuovinox product had received strong acceptance and a
large number of orders. Production of Nuovinox began in large quantities in the
first quarter 2001, the delay being caused by the development of processes
unique to the product, development that had not been completed and implemented
successfully when the Company's subsidiary entered into receivership in March
2002.

In fiscal 1999, at the end of which the Company ceased production of stainless
steel, the Company incurred a loss of $3,150,498 and in fiscal 2000 incurred a
loss of $2,279,926. These losses continued as increased production began on the
Nuovinox product in fiscal 2001 when the Company incurred a loss of $2,902,573.
Because the Company incurs a substantial amount of depreciation and
amortization, $506,050 in fiscal 1999 $538,673 in fiscal 2000, and $555,231 in
fiscal 2001, the cash losses for fiscal 1999, 2000 and 2001 were approximately
$2,640,000, $1,740,000 and $2,450,000, respectively.

In fiscal 1999 the cash loss of approximately $2,640,000 was principally funded
through the liquidation of current assets. Between March 31, 1998, and March 31,
1999, the Company's cash position decreased from $852,892 to $42,973,
receivables decreased from $597,426 to $19,505 and inventories decreased from
$948,093 to $195,663, a reduction in current assets of $2,140,271. The amount of
the cash loss that was not funded through the liquidation of current assets as
well as some increases in property were funded through sales of common stock
that netted $726,670.

In fiscal 2000 the cash loss of approximately $1,740,000 was funded through
financing activities. A related party loaned the Company approximately
$1,000,000 and the Company issued Common Stock, the sale of which resulted in
net proceeds to the Company of approximately $800,000.

In fiscal 2001, cash losses were funded through a line of credit.

In fiscal 2002, there were no other sources of funds to cover cash losses and in
March 2002, the U.K. subsidiary entered into receivership.

The Company has entered into a letter of intent to acquire for $1,750,000 from
Wells Fargo Bank the Company's assets transferred to it as a result of the
receivership. Presently, the Company has a backlog of $2,500,000 in orders. It
is attempting to obtain financing of $3,000,000 to acquire the assets and obtain
operating capital to begin production to deliver the Nuovinix product.
Management of the Company believes that operational problems that prevented
efficient production have been solved such that the Company can be profitable
and cash flow positive following this financing.

Nonetheless, the Company's audit report is qualified because of the concern over
the Company's ability to continue as a going concern.

2002 versus 2001

By the end of fiscal 2001 on March 31, 2001, the Company had used the maximum
amount available under the Loan Agreement. The Company had to reduce staffing
and limit production in the second quarter of fiscal 2002 due principally to the
unavailability of capital to expand production and meet demand.

Nonetheless, the Company's revenues increased to $559,170 in fiscal 2002 period
compared to revenues of $304,377 in the earlier period. Cost of sales in fiscal
2002 were 1,453,399 compared to 1,021,209 in 2001, that is, in fiscal 2002 each
$1.00 in revenue cost about $2.60 compared to $1.00 in revenue in fiscal 2001
costing about $3.63. The more favorable result in fiscal 2002 reflects greater
volume productions obtained in that year but the expense reflects that
inefficiencies still existed that prohibited the Company to operate. General and
administrative expenses declined in the later period as the Company attempted to
scale back operations without working capital. increased significantly as the
Company began to staff to levels required to support full production. Finally,
the Company incurred significant interest expense of $656,276 in fiscal 2002,
essentially interest expense on the Loan Agreement.

Without adequate capital to effect efficient operations, the U.K. subsidiary was
placed into receivership in March 2002 with the consequence that the company
incurred a write-down of its investment in that subsidiary in the amount of
$7,346,348. With the $2,295,227 loss from operations, the Company's net loss was
$10,295,346.

2001 versus 2000

The Company incurred a net loss of $2,902,573 in fiscal 2001 compared to a net
loss of $2,279,926 in fiscal 2000. The principal increases in expenses that
contributed to this loss were an increase of interest expense to $465,032 from

$90,785 and an increase in Selling, general and administrative expenses to
$1,813,549 from $1,531,930. The Company's gross loss increased approximately
$60,000 in fiscal 2001 from $657,930 in the previous fiscal year.

The Company's credit facility from Bank of America became available in the first
quarter of fiscal 2001 but production of Nuovinox did not occur in any quantity
until the second quarter of fiscal 2001. This production was not, however,
large, reflecting the need for further developments in the manufacturing
processes and technical developments in the Nuovinox product.. The Company also
experienced some inefficiencies in production that arose from the first efforts
at production on a large scale. Accordingly, while revenues rose to $304,377 in
fiscal 2001 from $136,191 in fiscal 2000, fiscal 2001's revenues do not reflect
a significant level of production.

Nonetheless, the cost of sales for fiscal 2001 do reflect the staffing and other
costs that are required to engage in production of Nuovinox on a large scale.
Accordingly, cost of sales in fiscal 2001 increased to $1,021,209 from $794,121
in fiscal 2000, more than offsetting the increase in revenues in fiscal 2001 of
$168,186 from the previous year.

Inflation

The Company's operations may be impacted by the effects of inflation and
changing prices as increased prices may reduce the demand for steel products.
Additionally, the price of nickel has direct impact on the Company as nickel is
an integral component to the price of the stainless steel utilized in Nuovinox.

Accounting Policies

Stelax Industries's accounting policies are detailed in Note A to Financial
Statements. Stelax Industries follows US GAAP. In applying these accounting
policies in the preparation of Stelax Industries's financial statements,
management is required to make estimates and assumptions about future events
that affect the reporting and disclosure of assets and liabilities at the
balance sheet dates and the reported amounts of revenue and expense during the
periods covered. The following is a summary of certain critical accounting
policies of Stelax Industries which are impacted by judgments and uncertainties
and for which different amounts would be reported under a different set of
conditions or using different assumptions.

Revenue recognition -- Stelax Industries records revenue upon receipt and
acceptance by the customer. For the years ended March 31, 2002, 2001 and 2000,
there was no unbilled revenue included in total revenues.

Derivatives and financial instruments -- Stelax Industries accounts for
derivatives in accordance with Statement of Financial Accounting Standards
(SFAS) No. 133 "Accounting for Derivative Instruments and Hedging Activities".
SFAS No. 133 requires the recognition of derivatives in the balance sheet and
the measurement of those instruments at fair value. Changes in the fair value of
derivatives are recorded in earnings, unless (i) the normal purchase or sale
exception or (ii) cash flow hedge accounting is elected. At March, 31 2002, 2001
and 2000 there were no derivative or financial instruments to disclose.

CHANGES IN ACCOUNTING STANDARDS

On April 1, 2001, Stelax Industries adopted SFAS No. 133, "Accounting for
Derivative Instruments and Hedging Activities", as amended by SFAS No. 137 and
SFAS No. 138. (See Note A to Consolidated Financial Statements.) At March, 31
2002 there were no derivative or financial instruments to disclose.

SFAS No. 140, "Accounting for Transfers and Servicing of Financial Assets and
Extinguishments of Liabilities", became effective for Stelax Industries for
transfers on or after April 1, 2001. SFAS No. 140 revises the standards for
accounting for securitizations and other transfers of financial assets and
collateral and requires additional disclosures in its financial statements.
There have been no transfers to disclose, therefore SFAS No 140 has no impact in
the accompanying financial statements.

SFAS No. 141, "Business Combinations", became effective for Stelax Industries on
July 1, 2001. SFAS No. 141 requires the use of the purchase method of accounting
for business combinations initiated and completed after June 30, 2001 and
eliminates the use of the pooling-of-interests method. Stelax Industries have
not made any acquisitions in the year to March 31, 2002.

assessing potential impairment based upon the current fair value of the
reporting units and the discontinuance of goodwill amortization. In addition,
SFAS No. 142 requires completion of a transitional goodwill impairment test
within six months from the date of adoption. It establishes a new method of
testing goodwill for impairment on an annual basis or on an interim basis if an
event occurs or circumstances change that would reduce the fair value of a
reporting unit below its carrying value. Any goodwill impairment loss during the
transition period will be recognized as the cumulative effect of a change in
accounting principle. Subsequent impairments will be recorded in operations. At
March, 31 2002 all goodwill has been eliminated.

SFAS No. 143, "Accounting for Asset Retirement Obligations", will become
effective for Stelax Industries on April 1, 2003. SFAS No. 143 requires the
recognition of a fair value liability for any retirement obligation associated
with long-lived assets. The offset to any liability recorded is added to the
previously recorded asset and the additional amount is depreciated over the same
period as the long-lived asset for which the retirement obligation is
established. SFAS No. 143 also requires additional disclosures.

SFAS No. 144, "Accounting for the Impairment or Disposal of Long-Lived Assets",
will become effective for Stelax Industries as of April 1, 2003. SFAS No. 144
establishes a single accounting model, based on the framework established in
SFAS No. 121, "Accounting for the Impairment of Long-Lived Assets and for
Long-Lived Assets to be Disposed Of", for long-lived assets to be disposed of by
sale and resolves significant implementation issues related to SFAS No. 121.

For standards not yet adopted, Stelax Industries is evaluating the potential
effect on its financial position and results of operations.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

The Company does not engage in any hedging activities. In particular, the
Company does not hedge its sales for currency fluctuations, and, accordingly,
does not acquire market risk sensitive instruments. Over the last two fiscal
years, market risks have been negligible because of the small amount of
operations in which the Company has engaged.

The Company's primary market risk is anticipated to be a currency exchange rate
risk and the Company does not, at the present time, anticipate engaging in
management of that risk. For the next fiscal year, the Company's operations will
be principally conducted in the United Kingdom with sales anticipated in the
United States and Canada. In addition to currency market risk resulting from
trade accounts receivable, the Company anticipates any lending to be denominated
in U.S. Dollars. A significant increase in the Pound relative to Dollar would
make United States trade receivables worth less in the United Kingdom,
decreasing profit margins for products produced in the United Kingdom and sold
in the United States.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

See the consolidated financial statements beginning at page F-2 of this Form
10-K Annual Report.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE

Not applicable.

PART III

ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

Directors and Officers

The directors and executive officers of the Company as of March 31, 2000 are as
follows:

Name and Age Position Served In Office Since

Harmon S. Hardy, 73 Chairman of the 1987
Board, President
and Chief Financial Officer

Ruben Grubner, 46 Director 1995

William D. Alexander, 53 Director 1996

Harmon S. Hardy has been the President of the Company since its inception in
May, 1987 and is Chairman and President of various other entities. Mr. Hardy
devotes a substantial portion of his time to the matters and business of the
Company.

Ruben Grubner has been President of Altec Travel, a travel service firm in
Vancouver, B.C., Canada since 1978.

William D. Alexander is a Senior Vice-President with Bank of Nova Scotia in
Toronto, Canada and has been employed by the bank since 1987.

Compliance with Section 16(a) of the Securities Exchange Act of 1934

Section 16(a) of the Securities Exchange Act of 1934 requires the Company's
officers and directors, and persons who own more than 10% of a registered class
of the Company's equity securities, to file reports of ownership and changes in
ownership with the Securities and Exchange Commission. Officers, directors and
10% stockholders are required by regulations promulgated by the Securities and
Exchange Commission to furnish the Company copies of all Section 16(a) reports
they file.

The Company believes all Section 16(a) filing requirements applicable to its
officers, directors and 10% beneficial owners were complied with through March
31, 2002, except that the directors failed to file timely reports regarding the
grant of stock options.

ITEM 11. EXECUTIVE COMPENSATION

The following table sets forth information with respect to the compensation to
the Company's chief executive officer at March 31, 2000 for services rendered
during the fiscal years ended March 31, 2001, 2000, and 1999. The table includes
for the same periods those individuals receiving in excess of $100,000 per year.

Annual Compensation (1)
Stock All Other
Options Compensa-
Name Year Salary Bonus Other (Shares) tion
------------------------- --------- ------------ ------------- ----------- ------------ ------------

Harmon S. Hardy 2002 $ 144,000(5) $ - $ - - $ 9,000 (2)
Chariman of the 2001 $ 144,000 $ - $ - - $ 9,000 (2)
Board of Directors, 2000 $ 144,000 $ - $ - - $ 9,000 (2)

President and Chief
Financial Officer

A. Cacace 2002 $ 126,895 $ - $ - - $ 6,889 (4)
Managing Director 2001 $ 133,805 $ - $ - - $ 6,226 (4)
Of Stelax U.K. 2000 $ 145,800 $ - $ - - $ -

(1) The compensation described in the table does not include the cost to
the Company of benefits furnished to certain officers, including
premiums for health insurance, and other personal benefits provided to
such individuals that are extended in connection with the conduct of
the Company's business. No executive officer named above received other
compensation in excess of the lesser of $50,000 or 10% of such
officer's salary and bonus compensation.
(2) Includes a monthly car allowance which has been accrued but not paid.
(3) Mr. Cacace's salary was paid in Pounds Sterling and converted at the
rate of 1.41 pounds per Dollar. Of $126,895 salary, $88,738 was accrued
but not paid.
(4) Includes employment insurance.
(5) The entire amount was accrued but not paid.

2002 Option Grants

There were 200,000 options granted to Mr. Hardy during the fiscal year ended
March 31, 2002. In addition the exercise date on 1,350,000 of options granted to
Mr. Hardy was extended from January 2002 to January 2005 during the fiscal year
ended March 31, 2002. There were no options granted to Mr. Cacace during the
fiscal year ended March 31, 2002, however the exercise date on 500,000 of
options granted to Mr. Cacace was extended from January 2002 to January 2005
during the fiscal year ended March 31, 2002

See Item 13. Certain Relationships and Related Transactions.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth, as of March 31, 2002, the number and percentage
of outstanding shares of Common Stock beneficially owned by (i) each person
known by the Company to be a beneficial owner of more than five percent (5%) of
the Company's Common Stock; (ii) each of the executive officers of the Company;
(iii) each director of the Company; and (iv) all officers and directors as a
group:

Shares of Common
Stock Beneficially Percentage
Name and Address of Beneficial Owner (1) Owned of Class
--------------------------------------------------- -------------------------- ----------------

Harmon S. Hardy, Jr.
4004 Belt Line Road, Suite 107
Dallas, TX 75244 8,350,000 (2) 19.3%

Ruben Grubner 100,000 (3) *

William D. Alexander 200,000 (4) *

All Officers and Directors as a Group 8,650,000 20.0%

* Represents less than one percent

(1) The persons named in the table have sole voting and investment power with
respect to all shares of Common Stock showing as beneficially owned by them,
subject to community property laws, where applicable, and the information
contained in the footnotes to the table.

(2) Includes options to purchase 3,000,000 shares of common stock.

(3) Includes options to purchase 100,000 shares of common stock.

(4) Includes options to purchase 200,000 shares of common stock.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

As of March 31, 2002 and 2001, the Company owed an aggregate of $1,035,730 and
$960,328, respectively, to Mr. Hardy, the Company's President, and to his
affiliates. These amounts are payable on demand. Effective January 12, 1999, Mr.
Hardy began providing a line of credit up to $600,000 for the benefit of the
Company. The credit line bears interest at 10% per annum. The Company granted
600,000 warrants to purchase common stock of the Company at $0.30 per shares as
consideration of the credit line. In fiscal year 2000, the line of credit was
extended to $1,200,000 at the same interest rate, and the Company granted Mr.
Hardy a warrant to purchase an additional 600,000 shares of common stock for
$0.50 per share. The warrants may be exercised for a period of five years from
the date of the grant. At March 31, 2002 and 2001, $478,283 and $406,928 of the
total owed to Mr. Hardy represented draws on the line of credit and interest.

At March 31, 2002 and 2001, the Company owed to Mr. Cacace personally $nil and
$209,194, respectively.

On January 1, 1999, and again on December 15, 2000, Mr. Hardy and the President
of a subsidiary converted debt owed to each into common stock of the Company.
The conversion resulted in the Company issuing 1,125,000 and 1,500,000 shares of
common stock being issued in exchange for $225,000 and $375,000 of debt,
respectively. The exchange ratio was at current market price of the common
stock.

PART IV

ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON
FORM 8-K

(a) See "Index to Consolidated Financial Statements" included at F-1 of this
Form 10-K Annual Report for a listing of financial statements and
schedules filed as a part of this Form 10-K Annual Report.

(b) The following exhibits are filed as a part of this Annual Report on Form
10-K:

Exhibit
Number Description of Exhibit Location of Exhibit

3(a) Certificate of Incorporation of the Company a

3(b) Memorandum of Association of the Company a

3(c) Articles of the Company a

3(d) Amendment to Articles of the Company a

3(e) Amendment to Articles of the Company
changing the name to "Stelax Industries Ltd." c

4(a) Form of Stock Certificate a

4(b) Form of 7% Convertible Note due August 31, 1997 c

4(c) Form of Common Stock Purchase Warrant b

10(a) Sale and Purchase Agreement dated August 4, 1995 by and
between Shipyard Limited and ZX(UK) Limited
(c/k/a Stelax (U.K.) Limited) b

10(b) Agreement for Sale and Purchase of Assets by and between
Camborne Industries PLC (in receivership) and ZX(UK)
Limited(c/k/a Stelax (U.K.) Limited) b

10(c) Agreement relating to the land and buildings at Wern
Works, Briton Ferry Neath by and between Maritime
Transport Services Limited and ZX(UK) Limited (c/k/a
Stelax (U.K.)Limited) b

10(d) Variation Agreement dated November 13, 1995 by and between
Camborne Industries PLC and ZX(UK) Limited (c/k/a Stelax (U.K.)
Limited) b

10(e) Agreement dated November 13, 1995 by and between
Maritime Transport Services Limited and ZX(UK) Limited
(c/k/a Stelax (U.K.) Limited) b

10(f) Chattel Mortgage dated November 13, 1995 by and between
ZX(UK) Limited and Camborne Industries PLC (c/k/a Stelax
(U.K.) Limited) b

10(g) Patent Mortgage dated November 13, 1995 by and
between ZX(UK) Limited and Camborne Industries PLC (c/k/a
Stelax (U.K.) Limited) b
14

10(h) Trademarks Mortgage dated November 13, 1995 by and between
ZX(UK) Limited and Camborne Industries PLC (c/k/a Stelax
(U.K.) Limited) b

21(a) Subsidiaries of the Company

Stelax (U.K.) Limited, a United Kingdom subsidiary
Stelax USA, Inc., a Delaware corporation

*Filed herewith

a. Incorporated by reference from the Form S-18 Registration
Statement, as amended (No. 33-27667-FW), for the Company.

b. Incorporated by reference from the Form 8-K dated November 7,
1995.

[DELOITTE & TOUCHE LETTERHEAD]

INDEPENDENT AUDITORS' REPORT

To the Board of Directors and Stockholders of
Stelax Industries Ltd
British Columbia, Canada

We have audited the accompanying consolidated balance sheet of Stelax Industries
Ltd and subsidiary as of March 31, 2002 and 2001, and the related consolidated
statements of operations, stockholders' equity, and cash flows for each of the
three years in the period ended March 31, 2002. These financial statements are
the responsibility of the Company's management. Our responsibility is to express
an opinion on the financial statements and financial schedule based on our
audits.

We conducted our audits in accordance with auditing standards generally accepted
in the United States of America. Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.

In our opinion, such consolidated financial statements present fairly, in all
material respects, the financial position of Stelax Industries Ltd and
subsidiary as of March 31, 2002 and 2001, and the results of their operations
and their cash flows for each of the three years in the period ended March 31,
2002 in conformity with accounting principles accepted in the United States of
America.

The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern. As discussed in Note I to the
financial statements, at March 31, 2002, the Company was not in compliance with
certain covenants of its long-term loan agreement. The Company is attempting to
renegotiate the terms and covenants of the loan agreement and also is seeking
other sources of long-term financing. The Company's negative working capital,
its recurring losses from operations and its difficulties in meeting its loan
agreement covenants and financing needs, as discussed in Note I raise
substantial doubt about its ability to continue as a going concern. Management's
plans in regard to these matters are also described in Note I. The financial
statements do not include any adjustments that might result from the outcome of
this uncertainty.

/s/ DELOITTE & TOUCHE

DELOITTE & TOUCHE
Chartered Accountants
Cardiff, UK

Date August 23, 2002

F-1

Stelax Industries Ltd

CONSOLIDATED BALANCE SHEETS
(Presented in United States dollars)

ASSETS

March 31, March 31,
2002 2001
------------- -------------

CURRENT ASSETS:

Cash and cash equivalents $ 4,102 $ 800,696
Note Receivable 141,480 141,480
Accounts Receivable-Trade, net (allowance for
doubtful accounts at March 31, 2002 and 2001
$0 and $0, respectively) - 111,981
Receivable from related parties 3,000 -
Inventory-Raw materials - 23,851
Work in process - 35,128
Finished goods - 121,530
Prepaids and other current assets - 45,690
------------- -------------

Total Current Assets 148,582 1,280,356

PROPERTY & EQUIPMENT-AT COST:
Plant & Machinery - 9,489,345
Building - 848,843
Land - 270,136
------------- -------------

- 10,608,324
Accumulated Depreciation - (2,186,221)
------------- -------------

Total Property & Equipment - 8,422,103

INTANGIBLE ASSETS (patents)
(accumulated amortization of $0 and
$276,556 at March 31, 2002 & 2001,
respectively) - 566,135

OTHER ASSETS 102,934 201,804

TOTAL ASSETS $ 251,516 $ 10,470,398
============= =============

See notes to consolidated financial statements.
F-2

Stelax Industries Ltd

BALANCE SHEETS
(Presented in United States dollars)

LIABILITIES AND STOCKHOLDERS' EQUITY

March 31, March 31,
2002 2001
------------- -------------

CURRENT LIABILITIES:

Accounts payable $ 206,653 $ 767,707
Payable to related parties 1,035,730 960,328
Accrued interest 433,998 37,934
Note payable--short term 3,645,833 4,166,666
------------- -------------

Total Current Liabilities 5,322,214 5,932,635

STOCKHOLDERS' EQUITY:
Common stock - 50,000,000 shares authorized, no stated par value; issued and
outstanding 43,184,775 and 39,240,175 shares at March 31,
2002 and 2001, respectively 25,281,717 24,183,962
Cumulative translation adjustments 83,684 222,132
Accumulated deficit (30,436,099) (19,868,331)
------------- -------------

Total Stockholders' Equity $ (5,070,698) $ 4,537,763
------------- -------------

TOTAL LIABILITIES AND
STOCKHOLDERS' EQUITY $ 251,516 $ 10,470,398
============= =============

See notes to consolidated financial statements.

F-3

Stelax Industries Ltd.

CONSOLIDATED STATEMENTS OF OPERATIONS
(Presented in United States dollars)

Year Ended
--------------------------------------------------

March 31, March 31, March 31,
2002 2001 2000
------------- ------------- -------------

Sales $ 559,170 $ 304,377 $ 136,191
Cost of sales 1,453,399 1,021,209 794,121
------------- ------------- -------------

Gross loss (894,229) (716,832) (657,930)

Selling, general and administrative expenses
(including depreciation and amortization of
548,167, $555,231and $538,673 for the years
ended March 31,2002, 2001 and 2000,
respectively) 1,908,602 1,813,549 1,531,211
------------- ------------- -------------

Loss from operations (2,802,831) (2,530,381) (2,189,141)

Other income (expense):
Interest income 2,505 92,840 -
Interest expense (656,276) (465,032) (90,785)
Investment write-downs and other charges (7,111,166) - -
------------- ------------- ---------------

Net loss $ (10,567,768) $ (2,902,573) $ (2,279,926)
============= ============= =============

Weighted average shares of common stock
- basic and diluted 41,220,912 37,993,516 36,267,505
============= ============= =============

Net loss per share - basic and diluted $ (0.26) $ (0.08) $ (0.06)
============ ============ ============

See notes to consolidated financial statements.
F-4

Stelax Industries Ltd

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
(Presented in United States dollars)

Common Stock Total
Accumulated Translation Comprehensive
Shares Amount Deficit Adjustments Total Income
-------------- ------------- ------------- ----------- ------------ -------------

BALANCE at April 1, 1999 35,963,729 $22,885,219 $ (14,685,832) $ 202,864 $ 8,402,251 $ (3,188,135)

Common stock issued during the period:
$.51 to $.56 per share for note payable
conversion 725,000 354,453 - - 354,453 -
$.55 to $1.25 per share 257,713 187,800 - - 187,800 -
$.30 to $.95 per share for option exercise 575,000 258,750 - - 258,750 -
Foreign currency translation adjustment - - - (7,185) (7,185) (7,185)
Net loss - - (2,279,926) - (2,279,926) (2,279,926)
------------

COMPREHENSIVE LOSS (2,287,111)
-------------- ----------- ------------- ----------- ------------- ------------

BALANCE at March 31, 2000 37,521,442 $23,686,222 $ (16,965,758) 195,679 $ 6,916,143 $ (5,475,246)

Common stock issued during the period:
$.25 per share for related party note
payable conversion 1,500,000 375,000 - - 375,000 -
$.30 per share 82,733 24,820 - - 24,820 -
Stock for compensation $.72 per share 136,000 97,920 - - 97,920 -
Foreign currency translation adjustment - - - 26,453 26,453 26,453
Net loss - - (2,902,573) - (2,902,573) (2,902,573)
------------

COMPREHENSIVE LOSS (2,876,120)
-------------- ----------- ------------- ----------- ------------- ------------

BALANCE at March 31, 2001 39,240,175 $24,183,962 $ (19,868,331) 222,132 $ 4,537,763 $ (8,351,366)

Common stock issued during the period:
$.25 per share for related party note payable
conversion 3,100,000 775,000 - - 775,000 -
$.30 to $.50 per share 844,600 322,755 - - 322,755 -
Foreign currency translation adjustment - - (138,448) (138,448) (138,448)
Net loss - - (10,567,768) - (10,567,768) (10,567,768)

COMPREHENSIVE LOSS (10,706,216)
-------------- ----------- ------------- ----------- ------------- ------------

BALANCE at March 31, 2002 43,184,775 $25,281,717 $ (30,436,099) 83,684 $ (4,659,828) $(19,057,582)
============== =========== ============= =========== ============= =============

See notes to consolidated financial statements.
F-5

Stelax Industries Ltd

CONSOLIDATED STATEMENTS OF CASH FLOWS
(Presented in United States dollars)

Year Ended
------------------------------------------------

March 31, March 31, March 31,
2002 2001 2000
------------- ------------- -------------

OPERATING ACTIVITIES

Net loss $ (10,567,768) $ (2,902,573) $ (2,279,926)
Adjustments to reconcile net loss
to net cash provided by operating
activities:
Depreciation & amortization 548,167 555,231 538,673
Allowance for doubtful accounts - - -
Foreign currency transaction gain(loss) (138,448) 26,453 (7,185)
Changes in operating assets and
liabilities:
Decrease (increase) in receivables 108,981 (49,534) (42,942)
Decrease (increase) in inventory
& other assets 325,069 (226,103) 1,263
Increase (decrease) in accounts
payable & accrued interest (89,588) (1,045,714) 1,148,246
-------------- ------------- -------------

Net cash (used) provided by operating
activities (9,813,587) (3,642,240) (641,871)

INVESTING ACTIVITIES

Purchase of property, equipment &
intangibles

Purchase of property, equipment &
intangibles 8,440,071 (266,130) (157,445)
------------- ------------- -------------

Net cash used by investing activities 8,440,071 (266,130) (157,445)

FINANCING ACTIVITIES:
Convertible note payable issue/repayment - 375,000 -
Net proceeds from common stock 1,097,755 122,740 801,003
Note payable issue (520,833) 4,166,666 -
-------------- ------------- -------------

Net cash provided by financing activities 576,922 4,664,406 801,003
------------- ------------- -------------

Increase (decrease) in cash and cash
equivalents (796,594) 756,036 1,687

Cash & cash equivalents at beginning
of year 800,696 44,660 42,973
------------- ------------- -------------

Cash & cash equivalents at end of year $ 4,102 $ 800,696 $ 44,660
============= ============= =============

Interest paid $ - $ 372,098 $ 31,034
============= ============= =============

Income taxes paid $ - $ - $ -
============= ============= =============

See notes to consolidated financial statements.
F-6

STELAX INDUSTRIES LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Presented in United States Dollars)

A. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

ORGANIZATION

Stelax Industries, Ltd. (a Canadian corporation) formerly Zfax Image Corp., (the
"Company") was incorporated on May 5, 1987, primarily to develop and produce
portable facsimile machines. These operations were conducted through the
Company's formerly owned subsidiary, Zfax, Inc.

On July 11, 1995, the Company incorporated Stelax (U.K.) Limited ("Stelax") as a
wholly owned subsidiary in the United Kingdom to acquire certain assets of a
steel mill in West Glamorgan, Wales and establish operations in the stainless
steel manufacturing business. The financial statements for the years ended March
31, 2001 and 2000 include the accounts of the Company and its U.K. subsidiary.
The operating loss of this subsidiary was $2,223,244, and $2,080,970 for the
years ended March 31, 2001 and 2000 and it had identifiable assets of $9,362,218
at March 31, 2000. All significant intercompany balances and transactions were
eliminated. On March 7, 2002 an Administrative Receiver was placed in the
subsidiary to manage the assets covered by the note payable agreement. The
financial statements at March 31,2002 consolidate the results of the subsidiary
up to March 7,2002, thereafter the subsidiary has been reported using the cost
method The operating loss of this subsidiary was $2,295,227 upto March 7 2002.
The company considers the investment in the subsidiary to be worthless
accordingly the investment has been written off resulting in a loss of
$7,111,166.

The Company's consolidated financial statements are presented in accordance with
accounting principles generally accepted in the United States of America (US
GAAP).

DECONSOLIDATION OF STELAX (U.K.)

Under generally accepted accounting principles consolidation is generally
required for investments of more than 50% of the outstanding voting stock of an
investee except when control is not held by the majority owner. Under these
principles, bankruptcy represents a condition which can preclude consolidation
as control rests with the bankruptcy court, rather than the majority owner.

March 7, 2002 an Administrative Receiver was appointed to Stelax (U.K.) pursuant
to a debenture instrument executed over the whole of the assets of the company
in favour of Bank of America Finance Corporation dated June 30 2000 and assigned
to Wells Fargo Business Credit Inc on April 20 20001. Accordingly from March
7,2002 control rests with the Receiver not Stelax Industries.

The results of Stelax (U.K.) have been consolidated up to March 7, 2002
thereafter Stelax (U.K) has been reported using the cost method. At March 7,2002
Stelax (U.K.) had net assets of $7,111,166 principally consisting of plant and
equipment at the Aberneath facility in South Wales, United Kingdom. However
Stelax Industries does not expect to recover any monies from the Receiver in
respect of this investment. This investment has therefore been written off, and
a loss of $7,111,166 has been recorded in the income statement for the year to
March 31,2002.

CASH AND CASH EQUIVALENTS

The Company considers all highly liquid investments with an original maturity of
three months or less when purchased to be cash equivalents.

LOSS PER SHARE

The computation of loss per share is based upon the weighted average shares of
Common Stock outstanding during the period.

F-7

STELAX INDUSTRIES LTD.
NOTES TO FINANCIAL STATEMENTS
(Presented in United States Dollars)

DEPRECIATION AND AMORTIZATION

Depreciation is provided using the straight-line method over the estimated
useful lives of their assets as follows:

Buildings 20 years
Plant and equipment 4 to 20 years
Intangible assets (Patents) 12 years

INVENTORY

The Company records raw material purchases at the lower of cost or market value
and records the disposition of inventory on a first-in, first out basis.
Inventory is evaluated periodically for obsolete items.

RESEARCH AND DEVELOPMENT

Research and development expenses are charged to operations as incurred. There
were no Research and development costs for the years ended March 31, 2002, 2001
and 2000.

START UP EXPENSES

All expenses incurred in connection with the start up of the steel mill have
been expensed as incurred. Expenses incurred in relation to the commissioning of
the planetary mill are capitalized as assets.

USE OF ESTIMATES

The preparation of the consolidated financial statements in conformity with US
generally accepted accounting principles requires management to make estimates
and assumptions that affect the amounts reported in the financial statements and
accompanying notes. Actual results could differ from those estimates.

IMPAIRMENT OF LONG-LIVED ASSETS

The Company accounts for impaired long-lived assets in accordance with Statement
of Financial Accounting Standards ("SFAS") No. 121 "Accounting for the
Impairment of Long-Lived Assets to be Disposed Of." This standard prescribes the
method for asset impairment evaluation for long-lived assets and certain
identifiable intangibles that are either held and used or to be disposed of. The
Company reviews the carrying values of its long-lived and identifiable
intangible assets for possible impairment whenever events or changes in
circumstances indicate that the carrying amount of assets may not be
recoverable.

COMPREHENSIVE INCOME

Comprehensive income is reported in accordance with SFAS No. 130, "Reporting
Comprehensive Income." Other comprehensive income includes foreign currency
translation adjustments.

OTHER ASSETS

Other assets consist primarily of the capitalized costs of financing and is
being amortized over the life of the loan.

INCOME TAXES

The Company uses the liability method of accounting for income taxes in
accordance with SFAS No. 109, "Accounting for Income Taxes." Under the liability
method, deferred income taxes are determined based upon enacted tax laws and
rates applied to the difference between the financial statement and tax bases of
assets and liabilities.

F-8

STELAX INDUSTRIES LTD.
NOTES TO FINANCIAL STATEMENTS
(Presented in United States Dollars)
SEGMENT INFORMATION

The Company reports segment information in accordance with SFAS No. 131,
"Disclosure about Segments of an Enterprise and Related Information." The
Company operates in one industry, the manufacture of steel related products, in
accordance with SFAS No. 131.

FOREIGN CURRENCY TRANSLATION

In accordance with the provisions of SFAS No. 52, "Foreign Currency
Translation," exchange adjustments resulting from foreign currency transactions
generally are recognized currently in income, whereas adjustments resulting from
translations of financial statements are reflected in accumulated other
comprehensive income (loss). The cumulative currency translation loss as of
March 31, 2002 was $83,684. Gains and losses on foreign currency transactions
for the fiscal years ended March 31, 2002 and March 31, 2001 resulted in net
foreign currency gains/(losses) of $(138,448) and $26,453 respectively.

FINANCIAL INSTRUMENTS

The fair values of financial instruments are determined by reference to various
market data and other valuation techniques, as appropriate. Unless otherwise
disclosed, the fair values of financial instruments approximate their recorded
values.

DERIVATIVE INSTRUMENTS

SFAS No. 133, "Accounting for Derivative Instruments and Hedging Activities" (as
amended by SFAS No. 137, "Accounting for Derivative Instruments and Hedging
Activities - Deferral of the Effective Date of FASB Statement No. 133")
establishes accounting and reporting standards for derivative instruments,
including certain derivative instruments embedded in other contracts
(collectively referred to as derivatives), and for hedging activities. It
requires that an entity recognize all derivatives as either assets or
liabilities in the statement of financial position and measure those instruments
at fair value. The Company does not have any items meeting the definition of a
derivative.

REVENUE RECOGNITION

In December 1999, the Securities and Exchange Commission issued Staff Accounting
Bulletin ("SAB") 101, "Revenue Recognition in Financial Statements", which
provides guidance related to revenue recognition based on interpretations and
practices followed by the SEC. SAB 101 requires companies to report any changes
in revenue recognition as cumulative change in accounting principle at the time
of implementation in accordance with Accounting Principles Board opinion 20,
"Accounting Changes." The Company's policy is to recognize revenue upon receipt
and acceptance by the customer.

BUSINESS COMBINATIONS

GOODWILL AND OTHER INTANGIBLE ASSETS

SFAS No. 142, "Goodwill and Other Intangible Assets", became effective for
Stelax Industries beginning April 1, 2002. SFAS No. 142 requires, among other
things, the allocation of goodwill to reporting units for the purpose of
assessing potential impairment based upon the current fair value of the
reporting units and the discontinuance of goodwill amortization. In addition,
SFAS No. 142 requires completion of a transitional goodwill impairment test
within six months from the date of adoption. It establishes a new method of
testing goodwill for impairment on an annual basis or on an interim basis if an
event occurs or circumstances change that would reduce the fair value of a
reporting unit below its carrying value. Any goodwill impairment loss during the
transition period will be recognized as the cumulative effect of a change in
accounting principle. Subsequent impairments will be recorded in operations. At
March, 31 2002 all goodwill has been eliminated.

F-9

STELAX INDUSTRIES LTD.
NOTES TO FINANCIAL STATEMENTS
(Presented in United States Dollars)

RETIREMENT OBLIGATIONS

LONG LIVED ASSETS

For standards not yet adopted, Stelax Industries is evaluating the potential
effect on its financial position and results of eperations.

B. RELATED PARTY TRANSACTIONS

As of March 31, 2002 and 2001, funds were due to the President and his
affiliates totaling $1,035,730 and $960,328 respectively. These amounts are
payable on demand. Effective January 12, 1999, the President of the Company
began providing a line of credit up to $600,000 for the benefit of the Company.
The credit line bears interest at 10% and 600,000 warrants to purchase Common
Stock of the Company at $.30 a share were issued as consideration of such credit
line. In fiscal year 2000, the line of credit was extended to $1,200,000 at the
same interest rate. An additional 600,000 warrants were issued at $.50 a share.
The warrants are valid for five (5) years. At March 31, 2002 and 2001, $478,283
and $406,928 of the total owed to the President represented draws on the line of
credit and accrued interest.

At March 31, 2002 and 2001, the Company owed the President of the subsidiary
$nil and $209,194.

On December 15, 2000, the President of the Company and the President of the
subsidiary converted debt owed to each into Common Stock of the Company. The
conversion resulted in 1,500,000 common shares being issued in exchange for
$375,000 of debt, respectively. The exchange ratio was at current market price
of the Common Stock.

A receivable of $141,480 exists from employees and contractors of the Company.
There is no stated interest and no set repayment terms.

C. MAJOR CUSTOMER INFORMATION

One customer accounted for approximately 21% and another accounted for
approximately 14% of new sales in fiscal 2002. In fiscal 2001 one customer
accounted for approximately 50% of net sales.

D. MAJOR SUPPLIERS' INFORMATION

The Company purchased inventory from two suppliers during the fiscal year ended
March 31, 2001 accounting for 23% and 19% of total inventory purchases
respectively. As of March 31, 2001 the Company had $nil and $nil respectively in
amounts owed to these suppliers included in accounts payable. In 2002 the
Company purchased inventory from one supplier accounting for 24% of total
inventory purchased. As of March 31, 2002 the Company owed $nil to this
supplier.

F-10

STELAX INDUSTRIES LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Presented in United States Dollars)

E OPTIONS

The Company has granted stock options to certain directors, officers, employees,
investors and consultants to purchase shares of the Company's Common Stock under
a non-qualified plan. Additional options were issued in fiscal year 2002 at
prices ranging from $0.40 to $0.75 per share, which either approximates or
exceeds fair market value at date of grant. The options are valid for three to
five years.

A summary of the stock option transactions follows:

WEIGHTED
AVERAGE
NUMBER EXERCISE PRICE EXERCISE PRICE
OF SHARES PER SHARE PER SHARE
--------- -------------------- -------------------

Options outstanding March 31, 2000 7,105,000
Issued 225,000 $0.50-$0.85 $ 0.811
Options outstanding March 31, 2001 7,330,000
Issued 3,490,000 $0.40-$0.75 $ 0.514
Options outstanding March 31, 2002 10,790,000

Stock options are exercisable from date of grant until expiry date which range
from January 2002 to January 2005.

The Company accounts for its share options in accordance with Accounting
Principles Board Opinion No. 25 under which the compensation cost is recognized
based on the difference, if any, between the appraised fair value of the
company's stock at the time of option grant and the amount the employee must pay
to acquire the stock.

Statement of Financial Accounting Standards ("FASB") No. 123 "Accounting for
Stock Based Compensation" (SFAS 123) requires disclosure of pro forma
information regarding net income and earnings per share had compensation cost
been determined using the fair value method. The fair value of the Company's
stock based awards was estimated as of the date of grant using the Black-Scholes
option pricing model. Limitations on the effectiveness of the Black-Scholes
option valuation model are that it was developed for use in estimating the fair
value of trade options which have no vesting restriction and are fully
transferable and that the model requires the use of highly subjective
assumptions including expected stock price volatility. Because changes in the
subjective input assumptions can materially affect the fair value estimate, in
management's opinion, the existing models do not necessarily provide a reliable
single measure of the fair value of its stock based awards. The fair value of
options granted was estimated assuming no dividends and using the following
weighted average assumptions.

2002 2001 2000

Risk free interest rate 5.38% 5.12% 6.91%
Expected term 2-5 years 2-5 years 2-5 years
Volatility 154% 102% 109%
Weighted average fair value per share
for options granted during the year $0.51 $0.90 $0.49

F-11

STELAX INDUSTRIES LTD.
NOTES TO FINANCIAL STATEMENTS
(Presented in United States Dollars)

Had compensation costs for the Company's plan been recorded, the Company's net
loss and earnings per share would have been as indicated below:

2002 2001 2000

Net loss as reported $10,567,768 $2,902,573 $2,279,926
pro forma $11,320,702 $4,155,287 $3,269,729

Loss per share as reported $ 0.25 $ 0.10 $ 0.06
pro forma $ 0.24 $ 0.13 $ 0.09

F. COMMITMENTS AND CONTINGENCIES

The Company occupies corporate office space in Dallas, Texas on a month to month
lease, after completing a long term lease. Rent expense for fiscal year 2002,
2001 and 2000 respectively was $7,396, $17,714 and $17,714.

G. INCOME TAXES

The Company, as a Canadian corporation, does not file United States income tax
returns. The UK subsidiary will file tax returns in the United Kingdom.

Deferred income taxes reflect the net tax effects of temporary differences
between the carrying amounts of assets and liabilities for financial reporting
purposes and the amounts used for income tax purposes. The only component of
deferred taxes for the Company is its net operating loss carry forwards of
approximately $420,000 in Canada which began to expire in 1997 and $nil in the
U.K. Deferred tax assets at March 31, are:

2002 2001
------------ ------------
Deferred tax assets $ - $ 446,510
Valuation allowance (-) (446,510)
Net deferred-tax asset $ - $ -

The valuation allowance was decreased by $446,510 and $54,206 during the fiscal
years ended March 31, 2002 and 2001, respectively. Given the loss making
position of the Company, it is uncertain whether losses could be utilized in the
foreseeable future and therefore no benefit for deferred tax has been taken.

H. STOCKHOLDERS' EQUITY

Shares reserved for future issuance include 7,330,000 shares for stock options.
From time to time, the directors may declare and authorize payments of dividends
to the stockholders of record. To date, no dividends have been declared or paid.

In fiscal year 2000, Common Stock options totaling 2,040,000 were issued at $.50
to $1.10 per share. In fiscal year 2001, 225,000 Common Stock options were
issued at $.50 to $.85 per share. In fiscal year 2002, 1,770,000 Common Stock
options were issued at $.40 to $.85 per share.

Options on Common Stock totaling 1,622,000 were exercised in fiscal year 1999.
Option price was $.10 a share and the exercise occurred when current market
price ranged from $.20 to $.50 a share. The Company is financing 90% of the
exercise price on 1,572,000 shares. The note balance at March 31, 2001 and 2000
is $141,480.

During fiscal year 2000, convertible notes payable were sold and converted for a
net proceeds of $354,453 and resulted in 725,000 shares being issued.

F-12

STELAX INDUSTRIES LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Presented in United States Dollars)

In fiscal year 2001, related parties converted debt owed of $375,000 into common
shares of 1,500,000.

During fiscal year 2002, 2001 and 2000, 844,600, 82,733 and 257,713 Common Stock
shares were sold for either cash or services totaling $322,755, $24,820 and
$187,800, respectively.

During fiscal year 2000, 575,000 Common Stock options were exercised resulting
in $258,750 in cash. During fiscal year 2001, 136,000 Common Stock options were
exercised resulting in $97,920 in cash.

I. GOING CONCERN

The Company is in default of covenants and repayment schedules on the Term Loan,
Revolving Credit and Credit Accomodations with Wells Fargo Business Credit, inc.
As a result of these defaults on March 7,2002 Wells Fargo have appointed an
Administrative Receiver to the subsidiary under the terms of the debenture
instrument.

The Receiver therefore acquired control of the U.K. assets including the group's
Aberneath Steel Mill facility on March 7, 2002. The group's operations therefore
ceased from this point.

The Company has entered a letter of intent with Wells Fargo Business Credit inc
to acquire the U.K. assets for $1,750,000.

The Company's ability to execute this letter of intent and hence its ability to
continue as a going concern is dependent upon it being able to raise additional
funds.

The Company is confident that it will be able to raise sufficient funds to
execute the letter of intent and provide sufficient working capital to
re-commence and sustain production until the group becomes profitable.

The Directors are confident, with all the information available to them that the
company will continue to be a going concern.

J. NET LOSS PER SHARE

Losses per share have been computed in accordance with SFAS No. 128, Earnings
per Share. Basic and diluted losses per share are computed by dividing net loss
by the weighted average number of shares of Common Stock outstanding during the
year. Outstanding Common Stock options have been excluded from the calculation
of diluted losses per share because their effect would be antidilutive.

K. BANK FINANCING

In July 2000 the Company obtained a Term Loan as well as Revolving Credit and
Credit Accommodations. The balance of the loan at March 31, 2002 and 2001 is
$3,645,833 and $4,166,666. Due to the bank's positioning of an Administrative
Receiver in the subsidiary, the entire note payable is due in full.

In connection with the Loan Agreement the Company granted a warrant to Bank of
America Commercial Finance Corporation to purchase up to 160,000 shares of
Common Stock.

F-13

STELAX INDUSTRIES LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Presented in United States Dollars)

L. QUARTERLY FINANCIAL INFORMATION (UNAUDITED)

2002 Revenues Net Loss Net Loss Per Share
---- ---------- -------- ------------------

March $ (8,672) $ 8,019,158 $ 0.26
December 35,007 722,120 0.06
September 266,338 1,041,722 0.03
June 266,497 784,768 0.02

2001 Revenues Net Loss Net Loss Per Share
---- ---------- ----------- ------------------

March $ 76,355 $ 845,101 $ 0.02
December 39,029 911,162 0.02
September 55,824 677,314 0.02
June 133,169 468,996 0.01

2000

March $ 49,120 $ 757,929 $ 0.02
December (6,372) 513,558 0.01
September 49,854 547,489 0.02
June 43,589 460,950 0.01

F-14

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.

August 23, 2002 STELAX INDUSTRIES, LTD.

/s/ Harmon S. Hardy, Jr.
-------------------------
By: Harmon S. Hardy, Jr.
President and Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report
has been signed below by the following persons on behalf of the registrant and
in the capacities indicated, on August 23, 2002.

NAME OFFICE

/s/ Harmon S. Hardy, Jr.
-------------------------
Harmon S. Hardy, Jr. President and
(Principal Executive and Financial Officer) Chief Financial Officer

/s/ Ruben Grubner
------------------
Ruben Grubner Director

/s/ William D. Alexander
-------------------------
William D. Alexander Director